Short-Term Treatment of Moderate-to-Severe Alopecia Areata in Children With Baricitinib

Abstract

Keywords

alopecia areata baricitinib children

Get full access to this article

View all access options for this article.

References

Pratt

King

Messenger

Christiano

Sundberg

. Alopecia areata. Nat Rev Dis Primers. 2017;3:17011. doi:10.1038/nrdp.2017.11

King

Ohyama

Kwon

, et al. Two phase 3 trials of baricitinib for alopecia areata. N Engl J Med. 2022;386:1687-1699. doi:10.1056/NEJMoa2110343

Moussa

Eisman

Kazmi

, et al. Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: a retrospective review of 29 patients. J Am Acad Dermatol. 2023;88:1194-1196. doi:10.1016/j.jaad.2022.12.033

Asfour

Bokhari

Bhoyrul

, et al. Treatment of moderate-to-severe alopecia areata with baricitinib in preadolescent children. Br J Dermatol. 2023;189:248-250. doi:10.1093/bjd/ljad118

Zhao

Wei

Cai

Zhuo

Zhang

Lin

. Baricitinib therapy for paediatric patients with severe alopecia areata. J Eur Acad Dermatol Venereol. 2025;39:e82-e83. doi:10.1111/jdv.20108

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

76.84 MB

0.00 MB

0.02 MB

0.87 MB